50% Magnesium Sulfate Injection, Solution
Product Images NDC 51662-1235

50% Magnesium Sulfate injection is available in 10mL single-dose syringe for intravenous or intramuscular use. Each syringe contains 5g/10 mL (500 mg/mL) (4 mEq Mg**/mL) and MUST BE DILUTED FOR INTRAVENOUS USE. Hospira distributes the sterile injection, which has an osmolarity of 406 mOsmol/mi (calc). The injection contains not more than 75 /Lo haminu. The product is distributed by Hospira, Inc, Lake Forest IL60045 USA, and has LOT#ii-HiH-AR and EXP DMMMYYYY.*

50% Magnesium Sulfate Injection, USP in a 5 9/10 mL (500 mg/mL) vial. The lot number, expiration date, and dosage instructions are all provided on the label.*

This is a product label for Magnesium Sulfate Injection distributed by HF Acquisition Co., LLC. The label specifies that it contains 5 grams/10 ml (4 mEq Mg"‘*/ml) and should be used as per the manufacturer's instructions. The product is distributed from Mukilteo, WA 98275.*

This is a description of a pharmaceutical product called "50% Magnesium Sulfate Inj". It is a sterile solution that contains 5 grams of Magnesium Heptahydrate per 10 mL of solution. It must be diluted before intravenous use and may also be used intramuscularly. The solution may contain sulfuric acid and/or sodium hydroxide for pH adjustment. The medication and fluid path are sterile if the caps and protective cover are undisturbed and the package is intact. The usual dosage information is available in the insert. The product should be stored between 20°C to 25°C with excursions permitted between 15°C and 30°C. The original manufacturer's NDC is 0489-1754-18. This product is only available via prescription and is manufactured by HF Acquisition Cospkbe.*

This text appears to be a product label of a plastic syringe with the given code "0409-1754-10". It also mentions the volume and concentration of a substance called "V Isg/tomL" which is 50% and 4mg/mL respectively. Therefore, this label provides important information about the specifications of the syringe and the substance it can contain.*

This appears to be a description of a medication with instructions for use. The medication is ELLESTT Sulfate with a concentration of 5 g/10 mL (500 mg/mL) and a strength of 50%. The text provides instructions to use aseptic technique and remove the luer cover before pushing the plunger forward to relieve any resistance present. The barrel should be pulled down until air is expelled from the syringe. The medication must be diluted before intravenous use and has a warning of CAUTION. The medication is distributed by Hospira, Inc. However, it is unclear what the medication is used for or what condition it treats.*

This appears to be a set of instructions or guidelines for using a medical product called "Magnesium Sulfate Injection, USP" by Hospira Inc. The text provides steps for using the product with a syringe, and emphasizes the need to dilute the solution before intravenous use. There are also cautions related to the use of the product.*

Magnesium Sulfate Injection, USP 50% is a sterile solution for intravenous or intramuscular use. It comes in a 5 g/10 mL (500 mg/mL) single-dose syringe which must be diluted before intravenous use. The solution has a concentration of 4 mEq Mg**/mL and 4.06 mOsmol/mL (calc.). It contains not more than 75 mcg/L of aluminum and is distributed by Hospira, Inc. The label includes relevant product information such as NDC0409-1754-15, LOT ##-#HHH-AA, and EXP DMMMYYYY.*

This is a prescription medication containing 50% Magnesium Sulfate injection, Usp. It is available in a single-dose syringe with 5/10 mL (500 mg/mL) (4 mEq Mg**/mL) dosage. This medication must be diluted for intravenous use only and contains no more than 75 mg/L of aluminum. The manufacturer of this product is Hospira, Inc.*